Related Experiment Video

Updated: Aug 21, 2026

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
10:26

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes

Published on: January 16, 2015

Zebularine: a candidate for epigenetic cancer therapy

Jane Bradbury1

  • 1janeb@sciscribe.u-net.com

Drug Discovery Today
|October 27, 2004
PubMed

Insights

Epigenetic mechanisms, DNA modifications that alter gene expression, are crucial in cancer development. Zebularine, a DNA methylation inhibitor, is a promising new epigenetic therapy targeting these changes.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Traditional cancer therapy research focused on genetic mutations.
  • Epigenetic mechanisms, heritable gene expression changes without DNA mutation, are increasingly recognized as vital in cancer.
  • These epigenetic disruptions involve modifications like DNA methylation and histone alterations.

Discussion:

  • Zebularine is a stable inhibitor of DNA cytosine methylation.
  • It represents a novel approach to epigenetic therapy for cancer.
  • Understanding epigenetic dysregulation is key to developing targeted cancer treatments.

Key Insights:

  • Epigenetic alterations are significant drivers of cancer, alongside genetic mutations.
  • Zebularine directly targets DNA methylation, a key epigenetic process.
  • This highlights the therapeutic potential of epigenetic drugs in oncology.

Outlook:

  • Further development of Zebularine could lead to new cancer treatment strategies.
  • Epigenetic therapies offer a promising avenue for targeting cancer's complex mechanisms.
  • Continued research into epigenetic modifications will uncover more therapeutic targets.

More Related Videos

Zebrafish Model of Neuroblastoma Metastasis05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis09:45

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis

Published on: March 31, 2015

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...